Skip to main content
Pranabashis Haldar on Muck Rack

Pranabashis Haldar

As seen in: Nature, MDPI, Thorax, Microbiology Research, The Pathologist, Respiratory Medicine, ID Transmission
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Pranabashis

Contact Pranabashis, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Airway immune signatures of protection and disease progression in recent human tuberculosis household contacts

|
By William J. Branchett, Jessica Shields, Probir Chakravarty, Jo Lee, Hubert Slawinski, Katalin A Wilkinson, Robert Wilkinson, Anver Kamil, Raman Verma, Pranabashis Haldar, Anne O’Garra, Jee-Whang Kim, Ismail Novsarka
| Nature Verified
Abstract The local immune factors dictating whether individuals who have been infected with Mycobacterium tuberculosis remain healthy or progress to active tuberculosis (TB) have not been defined.
Open in Who Shared Issue with article?

Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight?

|
By Mirae Park, Giovanni Maria Satta, Pranabashis Haldar, NIHR Respiratory BRC
| Thorax Verified
Heteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight? Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Open in Who Shared Issue with article?

Bacteriophage Boost for TB Management

|
By Pranabashis Haldar
| The Pathologist Verified
Although collaborative efforts between non-government organizations and commercial entities are being formed to accelerate the development of new drugs to treat tuberculosis (TB) amid growing resistance, there is also a need for new diagnostics to identify individuals at risk of disease. But the causative pathogen – Mycobacterium tuberculosis (Mtb) – is a master of disguise and can remain hidden within the host for many years.
Open in Who Shared Issue with article?
See all 11 licensed articles (12 Total)